CCPG1
Basic information
Region (hg38): 15:55340032-55408510
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCPG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 38 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 10 | 21 | ||||
Total | 0 | 1 | 48 | 12 | 2 |
Variants in CCPG1
This is a list of pathogenic ClinVar variants found in the CCPG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-55340602-A-G | Developmental and epileptic encephalopathy, 80 | Pathogenic (Jan 07, 2024) | ||
15-55340603-C-T | Likely benign (Sep 21, 2022) | |||
15-55340604-G-A | Uncertain significance (Aug 02, 2022) | |||
15-55340612-T-C | Uncertain significance (Aug 06, 2022) | |||
15-55340618-C-T | Likely benign (Jan 01, 2023) | |||
15-55340621-G-C | Developmental and epileptic encephalopathy, 80 | Pathogenic (Oct 20, 2020) | ||
15-55340626-A-G | Likely benign (Nov 12, 2023) | |||
15-55340643-T-G | Uncertain significance (Aug 15, 2022) | |||
15-55340647-C-T | Likely benign (Aug 22, 2022) | |||
15-55340648-G-A | Uncertain significance (Aug 21, 2022) | |||
15-55340650-G-A | Likely benign (Dec 09, 2023) | |||
15-55340661-G-T | Developmental and epileptic encephalopathy, 80 • PIGB-related disorder | Benign (Feb 01, 2024) | ||
15-55340667-C-T | Inborn genetic diseases | Uncertain significance (Aug 05, 2022) | ||
15-55340668-A-C | Likely benign (Dec 13, 2023) | |||
15-55340668-A-G | Likely benign (Nov 13, 2023) | |||
15-55340677-TTCTCATCC-T | Pathogenic (Aug 17, 2023) | |||
15-55340686-A-G | Likely benign (Sep 01, 2022) | |||
15-55340692-C-T | Likely benign (Jul 30, 2023) | |||
15-55340716-A-C | Likely benign (Dec 27, 2023) | |||
15-55340719-T-A | Likely benign (Mar 26, 2023) | |||
15-55340721-T-C | Inborn genetic diseases | Uncertain significance (Oct 13, 2022) | ||
15-55340723-T-C | Likely benign (Aug 24, 2023) | |||
15-55340730-C-T | Uncertain significance (Dec 10, 2021) | |||
15-55340732-C-T | Uncertain significance (Nov 18, 2021) | |||
15-55340732-CACTT-C | Pathogenic (Dec 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCPG1 | protein_coding | protein_coding | ENST00000442196 | 8 | 68479 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000561 | 0.999 | 124760 | 0 | 34 | 124794 | 0.000136 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.990 | 350 | 406 | 0.862 | 0.0000199 | 5407 |
Missense in Polyphen | 97 | 149.37 | 0.64941 | 2069 | ||
Synonymous | -0.722 | 147 | 136 | 1.08 | 0.00000657 | 1382 |
Loss of Function | 3.54 | 12 | 34.5 | 0.348 | 0.00000173 | 475 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000415 | 0.000410 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000223 | 0.000223 |
Finnish | 0.0000931 | 0.0000928 |
European (Non-Finnish) | 0.000134 | 0.000132 |
Middle Eastern | 0.000223 | 0.000223 |
South Asian | 0.000165 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as an assembly platform for Rho protein signaling complexes. Limits guanine nucleotide exchange activity of MCF2L toward RHOA, which results in an inhibition of both its transcriptional activation ability and its transforming activity. Does not inhibit activity of MCF2L toward CDC42, or activity of MCF2 toward either RHOA or CDC42 (By similarity). May be involved in cell cycle regulation. {ECO:0000250, ECO:0000269|PubMed:9383053}.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.506
- rvis_EVS
- 0.6
- rvis_percentile_EVS
- 82.87
Haploinsufficiency Scores
- pHI
- 0.147
- hipred
- N
- hipred_score
- 0.340
- ghis
- 0.427
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0844
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccpg1
- Phenotype
Gene ontology
- Biological process
- cell cycle;positive regulation of cell population proliferation;positive regulation of cell cycle;positive regulation of transcription by RNA polymerase II;regulation of Rho guanyl-nucleotide exchange factor activity
- Cellular component
- integral component of membrane
- Molecular function
- molecular_function;protein binding